Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel

2021; Elsevier BV; Volume: 7; Linguagem: Inglês

10.1016/j.lanepe.2021.100150

ISSN

2666-7762

Autores

Gili Regev‐Yochay, Sharon Amit, Moriah Bergwerk, Marc Lipsitch, Eyal Leshem, Rebecca Kahn, Yaniv Lustig, Carmit Cohen, Ram Doolman, Arnona Ziv, Ilya Novikov, Carmit Rubin, Irena Gimpelevich, Amit Huppert, Galia Rahav, Arnon Afek, Yitshak Kreiss,

Tópico(s)

COVID-19 Clinical Research Studies

Resumo

BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority.

Referência(s)